|Dataset type:||Expression profiling by array|
|Number of samples:||3|
|Release date:||Dec 1 2018|
|Last update date:||Jan 23 2019|
|Dataset link||Targeting EphA4 abrogates intrinsic resistance to chemotherapy in well-differentiated tumors|
3 samples Caski cells were grown with cisplatin (20μM) or cisplatin plus C1(EphA4 inhibitor) for 12h, and purified using the RNeasy kit (Qiagen, Valencia, CA). For the first experiment (experiment 1; cisplatin-induced changes in gene expression in Caski cells with the aim of determining changes in gene expression that are modulated by cisplatin), the data were normalized to the median of untreated control Caski cells. For the second experiment (experiment 2; cisplatin-induced changes in gene expression in Caski cells treated with or without C1), the data were normalized to the median of samples without C1.